Be the Change. Do Something.

Slides:



Advertisements
Similar presentations
M. Fe Caces, Ph.D. Statistician/Demographer Office of National Drug Control Policy Executive Office of the President Washington, DC Presentation for the.
Advertisements

Opioid Update F ederation of S tate M edical B oards Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain July 2013 F ederation.
Maintenance Phase Judith Martin, MD Medical Director, The 14 th Street Clinic, Oakland.
Innovative Approach of Managing High Risk Chronic Opioid Users in a Residency Practice Erin Inglis, MD a, Jessie Burch, PharmD b, Nida Awadallah, MD c,,
Chronic Pain Management Elaine Wendt, MD. Pain is now “Fifth Vital Sign”
Controlling Off-Label Narcotics Usage - Impact of New Arizona Legislation ARS §
QIPS All Section Call Opiate use in the ED. Objectives Identify the key components of opiate contracts and principles of how to use them effectively.
Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.
VCU Chronic Nonmalignant Pain Management: An Online Curriculum Leanne M. Yanni, MD Creator & Editor VCU Medical Center November 16 th, 2007.
Incorporating Best Practices through Practice Organization & EMRs in a Residency Practice Mathew Devine, D.O. Associate Medical Director Highland Family.
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
Introducing the Medication Recording System Schedule Ed Castagna Mom & Pop’s Small Business Services.
Alcohol & drugs Driver. Name of person who will answer driver questions about the materials Drivers subject to Part 382 1a Information drivers must receive.
For Pain or Not for Pain: Methadone Madness
Pain Management Laura Bergs FNP. Definition of Chronic Pain Anyone with pain greater than 3 months Anyone with pain greater than 3 months Pain An unpleasant.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Opioid Use in Workers’ Compensation Suzanne Novak, MD, PhD November 2008.
Study Finds Persons Who Fill Buprenorphine Prescriptions Have Higher Rates of Medical Conditions Associated with Pain and Comorbid Psychiatric Disorders.
Problem Behaviors Norman Wetterau. Less serious Ran of out pills three days early After one year lost pills Had a headache and a friend gave her a vicodin.
Pain Management- Hydrocodone Lara Offenburger PA-C No Disclosures ©AAHCM.
Don Teater MD Medical Advisor National Safety Council Itasca, IL Medical Provider Behavioral Health Group Asheville, NC Medical Provider Meridian Behavioral.
Prevention, Identification and Treatment of Opioid Use Disorders: A Personal Perspective Leah Bauer, MD Medical Director, Addiction Resource Center, Mid.
TNSAM Addiction Medicine. Data source: Tennessee Department of Health, Office of Health Statistics, Death Statistical System. Overdose deaths were defined.
Implementing a Urine Drug Screening Protocol to Teach Appropriate Opioid Prescribing in a Residency Practice STFM Annual Conference May 2, 2016 Nata Young,
Chapter 13 Section 2. Chi-Square Test 1.Null hypothesis – written in words 2.Alternative hypothesis – written in words – always “different” 3.Alpha level.
Medicated Assisted Treatment (MAT) Terry R. Jones Director of Behavioral Health.
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
Prescription Drug Monitoring Presented by: Len Abbott, Ph.D. Director Science and Technology Kathleen Valentine, General Manager PDM & Toxicology May 14,
Sarah Thompson, PharmD, CDOE Director of Clinical Services, Coastal Medical.
Denis G. Patterson, DO Nevada Advanced Pain Specialists Contact Information.
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
People with chronic pain are often prescribed methadone, a type of analgesic medicine to reduce pain. This medicine is also given.
What Our Patients Look Like
Table Organization Mix disciplines at each table please.
Georgia Nurse Protocol Agreement
Wireless Access SSID: cwag2017
Examining Potential Misuse of Gabapentin Among Patients Admitted to an Inpatient Behavioral Health Unit Samuel Kubas a, Pharm.D. Candidate 2018; Lucas.
The Role of Dentists in Preventing Opioid Abuse
Larry Halverson, MD Gabrielle Curtis, MD Cox FMR Springfield MO
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
Smartphone-Facilitated N-of-1 Trials for Improving Safety of Analgesic Regimens 1David Odineal, 2Rima Cabrera, 2Maria Marois, 2Sarah Benedetti, 2Peach.
6-Building Block Workshop
Medication-Assisted Therapy at Coleman Profession Services
Caldwell County Narcotic Initiative
COLLECTIVE IMPACT APPROACH TO ADDRESSING
Place name sticker or stamp with card
Peter Reuter (U. Maryland)
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
An Overview of the ePDMP
Frequently asked questions
Opioid Prescribing & Monitoring
Complete a legally valid prescription.
Controlled substance compliance
Controlled Substance Monitoring & Legislative updates
CSSW Alumni Conference
Barbara Allison-Bryan, MD
2017 Opioid Prescriber Survey Preliminary Results
Prescriber-Friendly Buprenorphine Delivery Model
Review why we’re doing this work Display survey results
Prescription Drug Monitoring Program
Prescription Drug Monitoring Program
National Credentialing Forum 2019 San Diego, CA February
Essentials of Good Pain Care: A Team-Based Approach
Chronic opioid therapy for non-cancer pain
More Than One-Third of Women in the U. S. Skip Care Because of Cost vs
Opioid prescribing workflow in the electronic medical record.
Strategic Initiatives to Address Opioid Overdose & Addiction
The Silent Killer in America
Presentation transcript:

Be the Change. Do Something. Copyright © The Stutman Switalski Group LLC 2017

Copyright © The Stutman Switalski Group LLC 2017

Copyright © The Stutman Switalski Group LLC 2017

Copyright © The Stutman Switalski Group LLC 2017 OVERPRESCRIBING People v. Cheng UNDERPRESCRIBING Bergman v. Chin Copyright © The Stutman Switalski Group LLC 2017

Suggested Best Practices for Compliance Program: Frequently monitor your statistical prescribing habits (6 months); Keep independent log and copies of C2 prescriptions and verify against PDMP Have a policy for random patient “Pill Counts”; Observed UDS; Have a plan for violations of PMC or CSA; Refer violators to Addiction Medicine; Consider alternative therapy; Office visit every 30 days for CII patients. Policy for verifying the validity of MRI, X-Rays; Demand complete medical records prior to first visit*; Document, document, document; Align treatment with functional goals; Pain Management Contracts (PMC) or Controlled Substance Agreements (CSA); Regularly update PMC or CSA; *Some only apply to Pain Management Physicians Copyright © The Stutman Switalski Group LLC 2017

#1: PATIENT HISTORY! DEVELOP A PROTOCOL NON- DISCRIMINATORY Copyright © The Stutman Switalski Group LLC 2017

Copyright © The Stutman Switalski Group LLC 2017

2016 Journal of Addiction Medicine October 6, 2016: Under-reporting of drug use among self-reported risky drug users: Amphetamines 66% Opiates 45% Cocaine 14% Marijuana 7% Under-reporting associated with history of incarceration and older age (p<0.05) Copyright © The Stutman Switalski Group LLC 2017

#2: URINE DRUG SCREENING Copyright © The Stutman Switalski Group LLC 2017

#3: PDMP #4: PILL COUNTS Copyright © The Stutman Switalski Group LLC 2017

Copyright © The Stutman Switalski Group LLC 2017

EROWID Copyright © The Stutman Switalski Group LLC 2017